Leaders in Medicine

Dr. Anne S. Renteria will work to build out its blood cancer programs.

Looking for “mutations driving the tumor or making it more sensitive to different drugs.”

The diagnosis was made when she was seven months pregnant.

She joins NYU Langone Health as section chief of pancreas surgery.

Fertility-sparing treatment was used increase the odds of her being able to start a family.

Dr. Shridar Ganesan’s background is in cancer biology and DNA repair.

The CEO and dean of NYU Langone spoke with STAT News about what sets it apart.

Dr. Nikhil Kumta will also serve as an associate professor in the Department of Medicine.

With few viable organs available from donors, a pioneering surgeon explores a bold alternative.

A pioneer in cardio-oncology treats cardiovascular conditions that can result from cancer therapies.